AmexDrug shows positive growth despite poor economic conditions

AmexDrug Corporation (OTCBB: AXRX), a US pharmaceutical and cosmeceutical company, is showing signs of growth despite poor economic conditions. These increases will be seen for the rest of the year, moving strong into 2010.

"We are thriving in the Health Care Industry," said Jack Amin, President and CEO of AmexDrug Corp. "Our vertical company manages, by and large, all aspects of manufacturing, packaging and distribution. We have expanded and operate in all 50 states!"

The significant increase in sales over the past year has boost revenues up 65.7% according to its 2009 Q2 results. Amin has credited much of the success to the last 12 months of marketing and his effective workforce. He expanded the company with an office into Asia Pacific this year.

"We currently have three subsidiaries and a superior manufacturing facility located in California, but we want to expand and grow. We want to acquire companies with whom an incorporation with AmexDrug Corp. will offer a mutual benefit," said Amin.